Twitter Beğeni Hilesi

📢We're excited to launch the EASL Liver Cancer Summit 2025, happening on 20-22 February 2025 in Paris, France! Check the scientific programme, plan your attendance, and submit your research. The field of primary liver cancer is rapidly evolving, with new treatments

🌟 Estrogen boosts LCAT, a key player in fighting hepatocellular carcinoma (HCC). High LCAT and HDL-C levels slow tumor growth and could be game-changers for HCC treatment. 🚀🔬 #CancerResearch #HCC Read here: ow.ly/8hZx50SUeCm

Excited to share our latest paper on burden of liver diseases and HCC in Asia Pacific Region in Nature Reviews Gastroenterology & Hepatology! 🚀 Check it out here: doi.org/10.1038/s41575… #Research #NewPublication #Science #Innovation

📢Check our September issue ‼️ 💥Featured article: Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC🔗bit.ly/3yJhR8Z Full issue here👉bit.ly/36khmDF #LiverTwitter Paolo Angeli EASL Education EASLnews

Mirror mirror on the wall Which of these risk scores is fairest of all LiverRisk SAFE APRI FIB-4 Three databases. One study. In Hepatology Communications journals.lww.com/hepcomm/fullte…

💉HCC Patients achieving a durable response with ATEZO/BEV i.e a PR or SD tend to have much more favourable outcome. ➡️mOS not estimatable for patients with durable PR ➡️mOS 23.7 months for durable SD ➡️pCR more frequent with PR (57%) Journal of Clinical Oncology Yakup Ergün Dr Amol Akhade

This team! getting ready to evaluate AI for HCC screening...for the time in Africa (as far as I know) 💪💪💪 Kilimanjaro Christian Medical Centre Foundation for Cancer Care in Tanzania CDC Tanzania University of Minnesota Africa HepatoPancreatoBiliary Cancer Consortium

Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression: Cancer Cell cell.com/cancer-cell/fu…

Global prevalence of advanced liver fibrosis and cirrhosis in the general population: a systematic review and meta-… pubmed.ncbi.nlm.nih.gov/39209202/

Get ready for #EASLStudio Season 7! 🥳 🎥 Dive into the latest insights and discussions on liver health with top experts. Don't miss the first episode today 04 September at 18:00 CEST 🔗easl.eu/easl-studio-ep… @EASLNews Debbie Shawcross Salvatore Piano Aleksander Krag

Multidisciplinary care is vital for optimal management of patients with liver cancer! Join Society for Immunotherapy of Cancer and AASLD Nov. 18 at #TLM24 for a collaborative session that introduces and discusses novel paradigms of HCC management. Register: ow.ly/fNeS50TeotL Neehar Parikh

ITT outcomes of pts with HCC receiving immunotherapy before liver transplant Journal of Hepatology doi.org/10.1016/j.jhep… 🔎🇺🇸VITALITY study 👉86 pts 👉75.6% downstaged 👉36% LTx 👉3-year ITT OS 71.1% 👉 7 rejections, 1 graft lost 🧐More evidence to support ICI before LTx ESMO - Eur. Oncology

It's National Healthy Whole Grains Month! US dietary guidelines recommend 3x 3oz servings of #wholegrains per day for adults. #liverhealth #HepatitisB #WholeGrainsMonth wholegrainscouncil.org/get-involved/c…

September is #Fruits^Veggies Month! For everyone, including ppl w/ #hepB & at risk for #livercancer, eating “cruciferous vegetables” (cabbage, broccoli, cauliflower) can protect the #liver against environmental chemicals.  Learn more #healthy liver tips: hepb.org/treatment-and-…

Join us for the 5th Intnl HBV Community Forum on Sept 11! Attend in person or online. A fantastic & FREE opportunity for researchers & community members to connect! Register for just the Community Forum: hbvmeeting.eventsair.com/2024-internati… Attend online only: us02web.zoom.us/webinar/regist…

For Natl Day of Service & Remembrance, we advocate against military #discrimination of #hepatitisB, a main cause of #livercancer. Since 2013, @hepBfoundation & civil rights advocates have urged Dept of Defense to update old #hepB policies. Learn more: ow.ly/no5I50TgLaH

#LiverTwitter #HepatitisB Important study by Grace Wong and team: #445 #HBV pts at highrisk for #HCC Dynamics in #ELF (Enhanced Liver Fibrosis) score risk-stratifies #HBV pts for their #HCC risk - independently from #LiverStiffness #LSM 📰 #JVirHep⏩ t.ly/1nEP2

September is #HealthyAgingMonth. #HepatitisB can lead to deadly #cirrhosis or #livercancer if left unchecked and can affect people of all ages. Talk to your doctor about getting tested for #hepB today!

The ILCA Annual Conference in Toronto from 17-19 October is the place to be not only to explore the latest scientific advancements in #livercancer research but also to deepen your focus on patient-centered care.

📊 New study on advanced liver cancer shows varied progression with combo therapies: 5.3–5.8 months to first progression, 8.7–9.3 months to second. Key progression sites are lymph nodes and lungs. #HCC #CancerResearch #Oncology Read here: ow.ly/1jQv50TkzxS